EFFICACY OF CERAMIC POROUS HYDROXYAPATITE AND PLATELET RICH PLASMA IN THE TREATMENT OF INTRABONY PERIODONTAL DEFECTS: A COMPARATIVE RANDOMIZED CLINICAL AND RADIOGRAPHIC STUDY

Cite this:
[1]
T. D. P. K. M. R. Saranyan R, Basha P. M*, “EFFICACY OF CERAMIC POROUS HYDROXYAPATITE AND PLATELET RICH PLASMA IN THE TREATMENT OF INTRABONY PERIODONTAL DEFECTS: A COMPARATIVE RANDOMIZED CLINICAL AND RADIOGRAPHIC STUDY”, ijmhs, vol. 2, no. 2, Oct. 2013.
© 2022 Interactive Protocols
RIGHTS & PERMISSIONS
Article Views
174
Altmetric
1
Citations
-
LEARN ABOUT THESE METRICS
   PDF  

Abstract

Periodontal regeneration is no longer an enigma but now a reality and hence the challenge of periodontal regeneration has come to forefront of research and practice. The aim of the present clinical study was to assess the regenerative potential of porous hydroxyapatite bone graft verses platelet rich plasma, in comparison with open flap debridement in treatment of periodontal intrabony defects. In this study about 30 periodontal intrabony defects in 10 patients, between the age group of 25- 45 were randomly divided into three groups viz., Group-A open flap debridement; group-B bone graft; group-C platelet rich plasma and followed up for a period of 6-months. The clinical and radiographic parameters were assessed in each group at baseline, 3-months and 6-months period. A statistically significant improvement in clinical parameters was observed from baseline to six month treatment period in all the three groups. The observed mean probing pocket depth at 6-months was 5.28 mm for group-A, 4.98 for group-B and 4.36 mm for group-C which was found to be statistically significant [p<0.05] while clinical attachment level were found to be 5.34 mm for group-A, 5.3 mm for group-B and 4.42 mm for group-C, Further, the percentage of radiographic resolution of the defect was found to be 40.8, 66.18 and 46.37% for groups A, B and C respectively. Thus bone grafting was found to be a better treatment modality when compared to open flap debridement and platelet rich plasma alone in treating periodontal intrabony defects.

KEYWORDS:

 Special Issue

Article Metrics Graph

Chart Graph | Range Graph

Content

Section

Source

License

All paper submissions must carry the following duly signed by all the authors:
“I certify that I have participated sufficiently in the conception and design of this work and the analysis of the data (wherever applicable), as well as the writing of the manuscript, to take public responsibility for it. I believe the manuscript represents valid work. I have reviewed the final version of the manuscript and approve it for publication. Neither has the manuscript nor one with substantially similar content under my authorship been published nor is being considered for publication elsewhere, except as described in an attachment. Furthermore I attest that I shall produce the data upon which the manuscript is based for examination by the editors or their assignees, if requested.”